News & Media
Search on our website
Type Enter to start searching.
Scroll to explore
Latest press releases
Scroll back top
8 April 2021
Domain Therapeutics presents most recent developments of its BRET technology portfolio at AACR and A...
8 December 2020
Domain Therapeutics launches Phase 1-enabling studies on proprietary EP4 receptor antagonist progra...
1 September 2020
Domain Therapeutics enters into a new collaboration agreement with Pfizer Inc. to profile signaling ...
22 June 2020
Domain Therapeutics presents posters at the American Association for Cancer Research Virtual Annual ...
4 May 2020
Domain Therapeutics receives development milestone payment from Merck KGaA, Darmstadt, Germany, fo...
3 March 2020
Domain Therapeutics acquires Prestwick Chemical and Neurofit to bolster next stage of growth
4 February 2020
Domain Therapeutics is granted European and US patent for biosensors assessing GPCR trafficking
13 January 2020
Domain Therapeutics secures €6 million ($6.7M) debt financing
17 December 2019
Domain Therapeutics and Pr Michel Bouvier (IRIC Montreal) receive the RSRI award for bioSens-All™ ...
30 September 2019
Domain Therapeutics reaches two milestones in multi-target research collaboration with Boehringer In...
News & Media